KEY FEATURES
| Full Name | Protein Kinase C Epsilon |
|---|---|
| Synonym | PKC-E; PRKCE; PRKC-E; NPKC-Epsilon |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 1.56-100ng/mL |
| Sensitivity | 0.62ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human PKCe in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PKCe. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PKCe and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PKCe, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PKCe. You can calculate the concentration of Human PKCe in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human PKCe ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 4.67 | 13.68 | 41.96 | 4.66 | 12.9 | 39.62 |
| Standard deviation | 0.24 | 0.68 | 2.14 | 0.29 | 0.62 | 1.88 |
| CV(%) | 5.2 | 4.94 | 5.1 | 6.26 | 4.79 | 4.75 |
RECOVERY
The recovery of Human PKCe spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-103 | 95 |
| EDTA plasma (n=8) | 86-101 | 92 |
| Cell culture media (n=8) | 94-108 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human PKCe in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with PRKCE ELISA Kits
| MAPK1 ELISA Kit | publications with PRKCE and MAPK1 |
| SRC ELISA Kit | publications with PRKCE and SRC |
| MAPK3 ELISA Kit | publications with PRKCE and MAPK3 |
| CFTR ELISA Kit | publications with PRKCE and CFTR |
| GNB2L1 ELISA Kit | publications with PRKCE and GNB2L1 |
| TRPV1 ELISA Kit | publications with PRKCE and TRPV1 |
| RAF1 ELISA Kit | publications with PRKCE and RAF1 |
| PECAM1 ELISA Kit | publications with PRKCE and PECAM1 |
| KRT1 ELISA Kit | publications with PRKCE and KRT1 |
| HK2 ELISA Kit | publications with PRKCE and HK2 |
Pathways associated with PRKCE ELISA Kit
| B Cell Receptor Signaling Pathway | B Cell Receptor Signaling Pathway |
| CDC42 Signaling Events Pathway | CDC42 Signaling Events Pathway |
| Calcium Regulation In The Cardiac Cell Pathway | Calcium Regulation In The Cardiac Cell Pathway |
| DAG And IP3 Signaling Pathway | DAG And IP3 Signaling Pathway |
| DAP12 Interactions Pathway | DAP12 Interactions Pathway |
| DAP12 Signaling Pathway | DAP12 Signaling Pathway |
| Disease Pathway | Disease Pathway |
| Downstream Signal Transduction Pathway | Downstream Signal Transduction Pathway |
| Downstream Signaling In Naive CD8+ T Cells Pathway | Downstream Signaling In Naive CD8+ T Cells Pathway |
| Downstream Signaling Of Activated FGFR Pathway | Downstream Signaling Of Activated FGFR Pathway |
Diseases associated with PRKCE ELISA Kit
| Cardiovascular Diseases | publications with PRKCE and Cardiovascular Diseases |
| Heart Diseases | publications with PRKCE and Heart Diseases |
| Myocardial Ischemia | publications with PRKCE and Myocardial Ischemia |
| Hypertrophy | publications with PRKCE and Hypertrophy |
| Reperfusion Injury | publications with PRKCE and Reperfusion Injury |
| Nervous System Diseases | publications with PRKCE and Nervous System Diseases |
| Necrosis | publications with PRKCE and Necrosis |
| Cardiomyopathies | publications with PRKCE and Cardiomyopathies |
| Myocardial Infarction | publications with PRKCE and Myocardial Infarction |
| Heart Failure | publications with PRKCE and Heart Failure |
Organs/Tissues associated with PRKCE ELISA Kit
| Muscle | publications with PRKCE and Muscle |
| Heart | publications with PRKCE and Heart |
| Brain | publications with PRKCE and Brain |
| Blood | publications with PRKCE and Blood |
| Liver | publications with PRKCE and Liver |
| Lung | publications with PRKCE and Lung |
| Skin | publications with PRKCE and Skin |
| Kidney | publications with PRKCE and Kidney |
| Embryonic Tissue | publications with PRKCE and Embryonic Tissue |
| Bone | publications with PRKCE and Bone |